Page last updated: 2024-08-24

ginkgolide b and Systemic Inflammatory Response Syndrome

ginkgolide b has been researched along with Systemic Inflammatory Response Syndrome in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (100.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Dhainaut, JF; Dreyfuss, D; Holzapfel, L; Le Tulzo, Y; Mira, JP; Schlemmer, B; Solet, JP; Tenaillon, A; Wolff, M; Zeni, F	1

Trials

1 trial(s) available for ginkgolide b and Systemic Inflammatory Response Syndrome

Article	Year
Platelet-activating factor receptor antagonist BN 52021 in the treatment of severe sepsis: a randomized, double-blind, placebo-controlled, multicenter clinical trial. BN 52021 Sepsis Study Group. Critical care medicine, 1994, Volume: 22, Issue:11 Topics: Adult; Aged; APACHE; Diterpenes; Double-Blind Method; France; Ginkgolides; Gram-Negative Bacterial Infections; Humans; Lactones; Middle Aged; Placebos; Platelet Activating Factor; Prognosis; Statistics as Topic; Systemic Inflammatory Response Syndrome	1994

Article

Year

Platelet-activating factor receptor antagonist BN 52021 in the treatment of severe sepsis: a randomized, double-blind, placebo-controlled, multicenter clinical trial. BN 52021 Sepsis Study Group.

Critical care medicine, 1994, Volume: 22, Issue:11

Topics: Adult; Aged; APACHE; Diterpenes; Double-Blind Method; France; Ginkgolides; Gram-Negative Bacterial Infections; Humans; Lactones; Middle Aged; Placebos; Platelet Activating Factor; Prognosis; Statistics as Topic; Systemic Inflammatory Response Syndrome

1994